3184.TWO MicroBase Technology Corp.
- Market cap
- TWD 868M
- P/E
- 20.1x
- P/B
- 1.40x
- ROE
- 4.6%
- Dividend yield
- 1.55%
- Fundamental score
- -
Ratios use the latest price and the fiscal year ending Dec 2025.
Is 3184.TWO undervalued?
Graham number3184.TWO trades 11.7% above its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
MicroBase Technology Corp. fundamental analysis
No fundamental analysis for MicroBase Technology Corp. yet.
MicroBase Technology Corp. stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About MicroBase Technology Corp.
MicroBase Technology Corp. engages in the research, design, manufacture, and sale of components and products of micro-atomization and micro-needles for medical, cosmetic and electronic applications in Taiwan. The company develops non-silicon-based micro-electro-mechanical systems. It offers industrial inkjet head; soft mist inhaler, for the treatment of chronic obstructive pulmonary disease, Pocket Air, an aerosol drug delivery solution; and soluble and insoluble microneedle…
Full company profileMicroBase Technology Corp. financial statements
MicroBase Technology Corp. annual financial statements (TWD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Income Statement | |||||||
| Revenue | - | 250M | 213M | 182M | 195M | 215M | 212M |
| Gross Profit | - | 81.8M | 80.5M | 61.1M | 93.8M | 120M | 113M |
| Operating Income | - | -75.6M | -30.7M | -13.7M | 21.5M | 53.2M | 45.9M |
| EBITDA | -15.1M | -43.9M | -13.5M | 27.3M | 46.9M | 83.6M | 43.6M |
| Net Income | -4.90M | -74.0M | -37.4M | 6.35M | 38.1M | 69.4M | 30.1M |
| EPS | -0.08 | -0.95 | -0.47 | 0.08 | 0.47 | 0.86 | 0.48 |
| Balance Sheet | |||||||
| Total Assets | - | 737M | 647M | 655M | 623M | 732M | 780M |
| Total Liabilities | - | 187M | 136M | 136M | 65.2M | 104M | 121M |
| Shareholders' Equity | - | 549M | 512M | 519M | 557M | 628M | 659M |
| Cash & Short-term Investments | 35.3M | 286M | 247M | 253M | 153M | 218M | 221M |
| Total Debt | - | 140M | 98.4M | 82.2M | 20.9M | 20.5M | - |
| Cash Flow | |||||||
| Operating Cash Flow | - | -40.2M | 12.1M | 57.9M | 37.4M | 70.8M | 40.2M |
| Capital Expenditure | 0.00 | 48.1M | 11.0M | 36.5M | 74.6M | 4.93M | 17.6M |
| Free Cash Flow | - | -88.3M | 1.14M | 21.4M | -37.2M | 65.8M | 22.6M |
| Ratios | |||||||
| ROE | - | -13.5% | -7.3% | 1.2% | 6.8% | 11.1% | 4.6% |
| ROA | - | -10.0% | -5.8% | 1.0% | 6.1% | 9.5% | 3.9% |
| Net Profit Margin | - | -29.6% | -17.5% | 3.5% | 19.6% | 32.3% | 14.2% |
| Debt to Equity | - | 0.26x | 0.19x | 0.16x | 0.04x | 0.03x | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
MicroBase Technology Corp. dividends
- Dividend yield
- 1.55%
- Forward dividend
- 0.22 TWD
- Payout ratio
- -
- Ex-dividend date
- Jul 13, 2026
Last stock split: 785.7349:1000 on Dec 2, 2025.
Who owns MicroBase Technology Corp.
Ownership data of MicroBase Technology Corp. is not available yet.
MicroBase Technology Corp. company profile
- Company name
- MicroBase Technology Corp.
- Ticker
- 3184.TWO
- ISIN
- TW0003184008
- Exchange
- Taiwan OTC Exchange
- Sector
- Technology
- Industry
- Electronic Components
- Fiscal year end
- December
- Address
- No. 756 Jiadong Road, Taoyuan City, Taiwan, 334015
- Phone
- 886 3 376 7555
- Website
- microbasetech.com
About MicroBase Technology Corp.
MicroBase Technology Corp. engages in the research, design, manufacture, and sale of components and products of micro-atomization and micro-needles for medical, cosmetic and electronic applications in Taiwan. The company develops non-silicon-based micro-electro-mechanical systems. It offers industrial inkjet head; soft mist inhaler, for the treatment of chronic obstructive pulmonary disease, Pocket Air, an aerosol drug delivery solution; and soluble and insoluble microneedles. MicroBase Technology Corp. was founded in 1997 and is based in Taoyuan City, Taiwan.
MicroBase Technology Corp. management
3- Tian Lai LiuGeneral Manager
- Zheng Xing GaoDeputy GM & Head of Finance Department
- Pei Ying HongAccounting Supervisor